Weight-loss drug stocks were catapulted into the spotlight in 2024, creating a lucrative, groundbreaking, and high-stakes ...

Semaglutide, or Ozempic as it is branded ... In research conducted by its billionaire manufacturer, the Danish-based ...

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Pensioenfonds Huisartsen, the occupational pension fund for general practitioners in the Netherlands, has published the names ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

The proposed Biosecure Act as well as the diversification of American and European firms away from China are expected to help ...

Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking ...